Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention

被引：21

作者：

Luis Ferreiro, Jose ^{[1
,2
]}

Antoni Gomez-Hospital, Joan ^{[2
]}

Cequier, Angel R. ^{[2
]}

Angiolillo, Dominick J. ^{[1
]}

Roura, Gerard ^{[2
]}

Teruel, Luis ^{[2
]}

Maristany, Jaume ^{[2
]}

Gomez-Lara, Josep ^{[2
]}

Jara, Francesc ^{[2
]}

Bass, Theodore A. ^{[1
]}

Esplugas, Enric ^{[2
]}

机构：

[1] Univ Florida, Coll Med Jacksonville, Jacksonville, FL 32204 USA

[2] Hosp Univ Bellvitge, IDIBELL, Dept Cardiol, Intervent Cardiol Unit, Barcelona, Spain

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2010年 / 145卷 / 02期

关键词：

Left ventricular assist device; Coronary revascularization; Impella Recover LP 2.5; MYOCARDIAL-INFARCTION; ASSIST DEVICE; CARDIOGENIC-SHOCK; TRIAL; FEASIBILITY; ANGIOPLASTY; SUPPORT; SAFETY;

D O I：

10.1016/j.ijcard.2009.08.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：235 / 237

页数：4

共 13 条

[1] Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty [J].

Briguori, C ;

Sarais, C ;

Pagnotta, P ;

Airoldi, F ;

Liistro, F ;

Sgura, F ;

Spanos, V ;

Carlino, M ;

Montorfano, M ;

Di Mario, C ;

Colombo, A .

AMERICAN HEART JOURNAL, 2003, 145 (04) :700-707

[2] THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE [J].

CHESEBRO, JH ;

KNATTERUD, G ;

ROBERTS, R ;

BORER, J ;

COHEN, LS ;

DALEN, J ;

DODGE, HT ;

FRANCIS, CK ;

HILLIS, D ;

LUDBROOK, P ;

MARKIS, JE ;

MUELLER, H ;

PASSAMANI, ER ;

POWERS, ER ;

RAO, AK ;

ROBERTSON, T ;

ROSS, A ;

RYAN, TJ ;

SOBEL, BE ;

WILLERSON, J ;

WILLIAMS, DO ;

ZARET, BL ;

BRAUNWALD, E .

CIRCULATION, 1987, 76 (01) :142-154

[3] Ethical authorship and publishing [J].

Coats, Andrew J. S. .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 131 (02) :149-150

[4] A Prospective Feasibility Trial Investigating the Use of the Impel la 2.5 System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (The PROTECT I Trial) Initial US Experience [J].

Dixon, Simon R. ;

Henriques, Jose P. S. ;

Mauri, Laura ;

Sjauw, Krischan ;

Civitello, Andrew ;

Kar, Biswajit ;

Loyalka, Pranav ;

Resnic, Frederic S. ;

Teirstein, Paul ;

Makkar, Raj ;

Palacios, Igor F. ;

Collins, Michael ;

Moses, Jeffrey ;

Benali, Karim ;

O'Neill, William W. .

JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (02) :91-96

[5] Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5 [J].

Henriques, JPS ;

Remmelink, M ;

Baan, J ;

van der Schaaf, RJ ;

Vis, MM ;

Koch, KT ;

Scholten, EW ;

de Mol, BAJM ;

Tijssen, JGP ;

Piek, JJ ;

de Winter, RJ .

AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (07) :990-992

[6] Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention [J].

Mishra, Sundeep ;

Chu, William W. ;

Torguson, Rebecca ;

Wolfram, Roswitha ;

Deible, Regina ;

Suddath, William O. ;

Pichard, Augusto D. ;

Satler, Lowell F. ;

Kent, Kenneth M. ;

Waksman, Ron .

AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (05) :608-612

[7] Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics [J].

Remmelink, Maurice ;

Sjauw, Krischan D. ;

Henriques, Jose P. S. ;

de Winter, Robbert J. ;

Koch, Karel T. ;

van der Schaaf, Rene J. ;

Vis, Marije M. ;

Tijssen, Jan G. R. ;

Piek, Jan J. ;

Baan, Jan, Jr. .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 70 (04) :532-537

[8] A Randomized Clinical Trial to Evaluate the Safety and Efficacy of a Percutaneous Left Ventricular Assist Device Versus Intra-Aortic Balloon Pumping for Treatment of Cardiogenic Shock Caused by Myocardial Infarction [J].

Seyfarth, Melchior ;

Sibbing, Dirk ;

Bauer, Iris ;

Froehlich, Georg ;

Bott-Fluegel, Lorenz ;

Byrne, Robert ;

Dirschinger, Josef ;

Kastrati, Adnan ;

Schoemig, Albert .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (19) :1584-1588

[9] A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty [J].

Stone, GW ;

Marsalese, D ;

Brodie, BR ;

Griffin, JJ ;

Donohue, B ;

Costantini, C ;

Balestrini, C ;

Wharton, T ;

Esente, P ;

Spain, M ;

Moses, J ;

Nobuyoshi, M ;

Ayres, M ;

Jones, D ;

Mason, D ;

Grines, L ;

ONeill, WW ;

Grines, CL ;

Sachs, D ;

Graham, M ;

McKinney, P ;

Jewett, H ;

Kreis, A ;

Brodsky, M ;

Friedman, H ;

Gangadharan, V ;

Goldman, L ;

Levin, R ;

Pavlides, G ;

Ramos, R ;

Safian, R ;

Savas, V ;

Schreiber, T ;

Ajluni, S ;

Almany, S ;

Boatman, J ;

StGoar, FG ;

Bavor, C ;

Constantino, R ;

Klughaupt, M ;

Saah, I ;

Bough, E ;

Osterle, S ;

McWard, C ;

Stuckey, TD ;

Weintraub, RA ;

Gregory, T ;

Bondy, DR ;

Lasorda, DM ;

Begg, R .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (07) :1459-1467

[10] Randomized comparison of intra-aortic balloon support with a percutaneous left ventricutar assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock [J].

Thiele, H ;

Sick, P ;

Boudriot, E ;

Diederich, KW ;

Hambrecht, R ;

Niebauer, J ;

Schuler, G .

EUROPEAN HEART JOURNAL, 2005, 26 (13) :1276-1283

← 1 2 →